Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast

Genes and Development

Volumn 10, Issue 3, 1996, Pages 279-288

  Alarcon, Clata M ^a   Cardenas, Maria E ^a   Heitman, Joseph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

immunosuppression; prolyl isomerases; RAFT1 kinase domain; rapamycin; Signal transduction; TOR; yeast

Indexed keywords

DRUG BINDING PROTEIN; RAPAMYCIN;

ARTICLE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; YEAST;

MAMMALIA;

EID: 0030026129     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.3.279     Document Type: Article

References (35)

1. Alani, E., L. Cao, and N. Kleckner. 1987. A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disruption yeast strains. Genetics 116: 541-545.
2. Albers, M.W., R.T. Williams, E.J. Brown, A. Tanaka, F.L. Hall, and S.L. Schreiber. 1993. FKBP-Rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. J. Biol. Chem. 268: 22825-22829.
3. Brown, E.J., M.W. Albers, T.B. Shin, K. Ichikawa, C.T. Keith, W.S. Lane, and S.L. Schreiber. 1994. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369: 756-759.
4. Browa, E.J., P.A. Beal, C.T. Keith, J. Chen, T.B. Shin, and S.L. Schreiber. 1995. Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature 377: 441-446.
5. Cafferkey, R., P.R. Young, M.M. McLaughlin, D.J. Bergsma, Y. Koltin, G.M. Sathe, L. Faucette, W.-K. Eng, R.K. Johnson, and G.P. Livi. 1993. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol. Cell. Biol. 13: 6012-6023.
6. Cardenas, M.E. and J. Heitman. 1995. FKBP12-Rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity. EMBO J. 14: 5892-5907.
7. Cardenas, M.E., M. Lorenz, C. Hemenway, and J. Heitman. 1994. Yeast as model-T cells. Perspect. Drug Discovery Design 2: 103-126.
8. Chen, J., X.-F. Zheng, E.J. Brown, and S.L. Schreiber. 1995. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc. Natl. Acad. Sci. 92: 4947-4951.
9. Chiu, M.I., H. Katz, and V. Berlin. 1994. RAPT1, a mammalian homolog of yeast Tor, interacts with the FBKP12/rapamycin complex. Proc. Natl. Acad. Sci. 91: 12574-12578.
10. de Groot, R.P., L.M. Ballou, and P. Sassone-Corsi. 1994. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression. Cell 79: 81-91.
11. Dumont, F.J., M.R. Melino, M.J. Staruch, S.L. Koprak, P.A. Fischer, and N.H. Sigal. 1990. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocol antagonists in murine T-cells. J. Immunol. 144: 1418-1424.
12. Harlow, E. and D. Lane. 1988. Antibodies: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
13. Heitman, J., N.R. Movva, and M.N. Hall. 1991a. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253: 905-909.
14. Heitman, J., N.R. Movva, P.C. Hiestand, and M.N. Hall. 1991b. FK506-binding protein proline rotamase is a target for the immunosuppressive agent FK506 in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. 88: 1948-1952.
15. Helliwell, S.B., P. Wagner, J. Kunz, M. Deuter-Reinhard, R. Henriquez, and M.N. Hall. 1994. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol. Biol. Cell 5: 105-118.
16. Ho, S.N., H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
17. Koerner, T.J., J.E. Hill, A M. Myers, and A. Tzagoloff. 1991. High-expression vectors with multiple cloning sites for construction of trpE fusion genes: pATH vectors. Methods Enzymol. 194: 477-490.
18. Koltin, Y., L. Faucette, D.J. Bergsma, M.A. Levy, R. Cafferkey, P.L. Koser, R.K. Johnson, and G.P. Livi. 1991. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. Mol. Cell. Biol. 11: 1718-1723.
19. 1 progression. Cell 73: 585-596.
20. Liu, J., J.D. Farmer, W.S. Lane, J. Friedman, I. Weissman, and S.L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815.
21. Lorenz, M.C. and J. Heitman. 1995. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J. Biol. Chem. 270: 27531-27537.
22. 1/S-phase growth arrest in T lymphocytes. J. Biol. Chem. 268: 3734-3738.
23. Rotonda, J., J.J. Burbaum, H.K. Chan, A.I. Marcy, and J.W. Backer. 1993. Improved calcineurin inhibition by yeast FBKP12-drug complexes. J. Biol. Chem. 268: 7607-7609.
24. Sabatini, D.M., H. Erdjument-Bromage, M. Lui, P. Tempst, and S.H. Snyder. 1994. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78: 35-43.
25. Sabatini, D.M., B.A. Pierchala, R.K. Barrow, M.J. Schell, and S.H. Snyder. 1995. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity. J. Biol. Chem. 270: 20875-20878.
26. Sabers, C.J., M.M. Martin, G.J. Brunn, J.M. Williams, F.J. Dumont, G. Wiederrecht, and R.T. Abraham. 1995. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem. 270: 815-822.
27. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
28. Schmitt, M.E., T.A. Brown, and B.L. Trumpower. 1990. A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res. 18: 3091-3092.
29. Schreiber, S.L. 1991. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251: 283-287.
30. Sikorski, R.S. and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122: 19-27.
31. Stan, R., M.M. McLaughlin, R. Cafferkey, R.K. Johnson, M. Rosenberg, and G.P. Livi. 1994. Interaction between FKBP12-Rapamycin and TOR involves a conserved serine residue. J. Biol Chem. 269: 32027-32030.
32. Van Duyne, G.D., R.F. Standaert, P.A. Karplus, S.L. Schreiber, and J. Clardy. 1991. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science 252: 839-842.
33. Wach, A., A. Brachat, R. Pohlmann, and P. Philippsen. 1994. New heterologous modules for classical or PCR- based gene disruptions in Saccharomyces cerevisiae. Yeast 10: 1793-1808.
34. Walsh, J.P., K.K. Caldwell, and P.W. Majerus. 1991. Formation of phosphatidylinositol 3-phosphate by isomerization from phosphatidylinositol 4-phosphate. Proc. Natl. Acad. Sci. 88: 9184-9187.
35. Zheng, X.-F., D. Fiorentino, J. Chen, G.R. Crabtree, and S.L. Schreiber. 1995. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 82: 121-130.